544
Views
18
CrossRef citations to date
0
Altmetric
Psoriasis

Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

, , , , , , , , , & show all
Pages 534-539 | Received 13 Nov 2017, Accepted 02 Feb 2018, Published online: 06 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Arjun M. Bashyam & Steven R. Feldman. (2020) Should patients stop their biologic treatment during the COVID-19 pandemic. Journal of Dermatological Treatment 31:4, pages 317-318.
Read now

Articles from other publishers (17)

Alexander J. Jafari, Kyle S. Owens, Shengping Yang, Lauren H. Chen, Katherine A. Jolin, Andrea T. Murina & Erin E. Boh. (2022) Differences in risk of herpes zoster infection across medication classes among psoriasis patients: a case–control study. International Journal of Dermatology 62:6.
Crossref
Laura Cannon, Alice Pan, Leonard Kovalick, Aliese Sarkissian & Eveline Y. Wu. (2023) Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies. Annals of Allergy, Asthma & Immunology 130:6, pages 718-726.
Crossref
David Singer, Philippe Thompson-Leduc, Deepshekhar Gupta, Wendy Y Cheng, Sara Poston, Siyu Ma, John E Pawlowski, Mei Sheng Duh, Eric D Morris, Francesca Devine & Francis A Farraye. (2023) Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn’s disease in the USA. Gastroenterology Report 11.
Crossref
Diamant Thaçi, Sascha Gerdes, Kristian Gaarn Du Jardin, Jean-Luc Perrot & Lluís Puig. (2022) Efficacy of Tildrakizumab Across Different Body Weights in Moderate-to-Severe Psoriasis Over 5 Years: Pooled Analyses from the reSURFACE Pivotal Studies. Dermatology and Therapy 12:10, pages 2325-2341.
Crossref
Linda Davidson, Juul M.P.A. Van den Reek, Florence Van Hunsel, Elke M.G.J. De Jong & Bart Jan Kullberg. (2022) Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center. Acta Dermato-Venereologica 102, pages adv00648.
Crossref
Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang & Yu-Huei Huang. (2022) Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis. Therapeutic Advances in Chronic Disease 13, pages 204062232210911.
Crossref
Joel V. Chua & John W. Baddley. 2022. Infectious Complications in Biologic and Targeted Therapies. Infectious Complications in Biologic and Targeted Therapies 69 87 .
Alexey A. Kubanov & Elena V. Bogdanova. (2021) What Are Patient Registries and Why Are They Needed (Through a Number of Examples of Psoriasis Registries). Annals of the Russian academy of medical sciences 76:2, pages 177-186.
Crossref
Zhenwei Tang, Minxue Shen & Xiang Chen. (2021) Risk of Herpes Zoster Among Psoriasis Patients Taking Biologics: A Network Meta-Analysis of Cohort Studies. Frontiers in Medicine 8.
Crossref
Sze-Wen Ting, Sze-Ya Ting, Yu-Sheng Lin, Ming-Shyan Lin & George Kuo. (2021) Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study. Scientific Reports 11:1.
Crossref
Chanyang Min, Dae Myoung Yoo, Miyoung Kim & Hyo Geun Choi. (2021) Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow‐up study using a national sample cohort. Australasian Journal of Dermatology 62:2, pages 183-189.
Crossref
Ailing Zou, Yongjun Chen, Nian Shi & Yu Ye. (2021) Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis. Medicine 100:40, pages e27368.
Crossref
M. Dubois, G. Morel, A. Tone, L. Gaboriau, S. Gautier, M. Lazrek & A. Vermersch-Langlin. (2020) Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab. Annales de Dermatologie et de Vénéréologie 147:10, pages 667-671.
Crossref
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye & Michael Boyle. (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 33:3.
Crossref
Xinwei Guo, Dongmei Zhou, Liyun Sun, Ping Wang, Jianhua Qu, Cang Zhang, Yan Wang, Zhaoxia Chen, Bo Li, Jing Hu, Zhimiao Lin, Fei Shi, Yanping Bai, Yuanwen Li, Xingwu Duan, Shentao Bao, Haibing Lan, Xiaoyan Sun, Xiong Wang, Xiang Liu, Linge Li, Litao Zhang, Fang Feng, Yujiao Meng, Qingwu Liu, Xiaoyao Guo, Jianning Guo, Yu Liu, Cong Qi, Jia Chen, Shuo Feng & Ping Li. (2020) Traditional Chinese medicine for psoriasis vulgaris. Medicine 99:41, pages e21913.
Crossref
Cory A. Kosche, Yasmeen Ali, Anna C. Figueiredo, Dennis P. West & Beatrice Nardone. (2019) Current Advances in the Prevention, Risk, and Management of Infection in Patients Receiving Biologic Therapy for Dermatologic Disorders. Current Dermatology Reports 8:3, pages 141-148.
Crossref
Karolina Vorčáková, Tatiana Péčová, Klára Martinásková, Katarína Nováčeková & Juraj Péč. 2019. Tailored Treatments in Psoriatic Patients. Tailored Treatments in Psoriatic Patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.